245 related articles for article (PubMed ID: 25132260)
21. Platelet-derived growth factor-A regulates lung fibroblast S-phase entry through p27(kip1) and FoxO3a.
McGowan SE; McCoy DM
Respir Res; 2013 Jul; 14(1):68. PubMed ID: 23819440
[TBL] [Abstract][Full Text] [Related]
22. Epidermal growth factor upregulates Skp2/Cks1 and p27(kip1) in human extrahepatic cholangiocarcinoma cells.
Kim JY; Kim HJ; Park JH; Park DI; Cho YK; Sohn CI; Jeon WK; Kim BI; Kim DH; Chae SW; Sohn JH
World J Gastroenterol; 2014 Jan; 20(3):755-73. PubMed ID: 24574749
[TBL] [Abstract][Full Text] [Related]
23. p27 Kip1 nuclear localization and cyclin-dependent kinase inhibitory activity are regulated by glycogen synthase kinase-3 in human colon cancer cells.
Wang Q; Zhou Y; Wang X; Evers BM
Cell Death Differ; 2008 May; 15(5):908-19. PubMed ID: 18408738
[TBL] [Abstract][Full Text] [Related]
24. Early mitotic inhibitor-1, an anaphase-promoting complex/cyclosome inhibitor, can control tumor cell proliferation in hepatocellular carcinoma: correlation with Skp2 stability and degradation of p27(Kip1).
Zhao Y; Tang Q; Ni R; Huang X; Wang Y; Lu C; Shen A; Wang Y; Li C; Yuan Q; Chen H; Cheng C; He S
Hum Pathol; 2013 Mar; 44(3):365-73. PubMed ID: 22995332
[TBL] [Abstract][Full Text] [Related]
25. WIF1, a Wnt pathway inhibitor, regulates SKP2 and c-myc expression leading to G1 arrest and growth inhibition of human invasive urinary bladder cancer cells.
Tang Y; Simoneau AR; Liao WX; Yi G; Hope C; Liu F; Li S; Xie J; Holcombe RF; Jurnak FA; Mercola D; Hoang BH; Zi X
Mol Cancer Ther; 2009 Feb; 8(2):458-68. PubMed ID: 19174556
[TBL] [Abstract][Full Text] [Related]
26. All-trans retinoic acid inhibits mesangial cell proliferation by up-regulating p21Waf1/Cip1 and p27Kip1 and down-regulating Skp2.
Su B; Chen X; Zhong C; Guo N; He J; Fan Y
J Nephrol; 2012; 25(6):1031-40. PubMed ID: 22344541
[TBL] [Abstract][Full Text] [Related]
27. Mutant B-RAF signaling and cyclin D1 regulate Cks1/S-phase kinase-associated protein 2-mediated degradation of p27Kip1 in human melanoma cells.
Bhatt KV; Hu R; Spofford LS; Aplin AE
Oncogene; 2007 Feb; 26(7):1056-66. PubMed ID: 16924241
[TBL] [Abstract][Full Text] [Related]
28. p27(Kip1) stabilization and G(1) arrest by 1,25-dihydroxyvitamin D(3) in ovarian cancer cells mediated through down-regulation of cyclin E/cyclin-dependent kinase 2 and Skp1-Cullin-F-box protein/Skp2 ubiquitin ligase.
Li P; Li C; Zhao X; Zhang X; Nicosia SV; Bai W
J Biol Chem; 2004 Jun; 279(24):25260-7. PubMed ID: 15075339
[TBL] [Abstract][Full Text] [Related]
29. Pim kinases promote cell cycle progression by phosphorylating and down-regulating p27Kip1 at the transcriptional and posttranscriptional levels.
Morishita D; Katayama R; Sekimizu K; Tsuruo T; Fujita N
Cancer Res; 2008 Jul; 68(13):5076-85. PubMed ID: 18593906
[TBL] [Abstract][Full Text] [Related]
30. STAT3 protein interacts with Class O Forkhead transcription factors in the cytoplasm and regulates nuclear/cytoplasmic localization of FoxO1 and FoxO3a proteins in CD4(+) T cells.
Oh HM; Yu CR; Dambuza I; Marrero B; Egwuagu CE
J Biol Chem; 2012 Aug; 287(36):30436-43. PubMed ID: 22761423
[TBL] [Abstract][Full Text] [Related]
31. CCN5 activation by free or encapsulated EGCG is required to render triple-negative breast cancer cell viability and tumor progression.
Das A; Haque I; Ray P; Ghosh A; Dutta D; Quadir M; De A; Gunewardena S; Chatterjee I; Banerjee S; Weir S; Banerjee SK
Pharmacol Res Perspect; 2021 Apr; 9(2):e00753. PubMed ID: 33745223
[TBL] [Abstract][Full Text] [Related]
32. Expression of Foxo3a in non-Hodgkin's lymphomas is correlated with cell cycle inhibitor p27.
Zhao Y; Fei M; Wang Y; Lu M; Cheng C; Shen A
Eur J Haematol; 2008 Aug; 81(2):83-93. PubMed ID: 18363870
[TBL] [Abstract][Full Text] [Related]
33. Gallic acid induces G2/M phase arrest of breast cancer cell MCF-7 through stabilization of p27(Kip1) attributed to disruption of p27(Kip1)/Skp2 complex.
Hsu JD; Kao SH; Ou TT; Chen YJ; Li YJ; Wang CJ
J Agric Food Chem; 2011 Mar; 59(5):1996-2003. PubMed ID: 21299246
[TBL] [Abstract][Full Text] [Related]
34. Regulation of Akt/FOXO3a/GSK-3beta/AR signaling network by isoflavone in prostate cancer cells.
Li Y; Wang Z; Kong D; Li R; Sarkar SH; Sarkar FH
J Biol Chem; 2008 Oct; 283(41):27707-27716. PubMed ID: 18687691
[TBL] [Abstract][Full Text] [Related]
35. Erlotinib, an effective epidermal growth factor receptor tyrosine kinase inhibitor, induces p27KIP1 up-regulation and nuclear translocation in association with cell growth inhibition and G1/S phase arrest in human non-small-cell lung cancer cell lines.
Ling YH; Li T; Yuan Z; Haigentz M; Weber TK; Perez-Soler R
Mol Pharmacol; 2007 Aug; 72(2):248-58. PubMed ID: 17456787
[TBL] [Abstract][Full Text] [Related]
36. Vitamin E δ-tocotrienol induces p27(Kip1)-dependent cell-cycle arrest in pancreatic cancer cells via an E2F-1-dependent mechanism.
Hodul PJ; Dong Y; Husain K; Pimiento JM; Chen J; Zhang A; Francois R; Pledger WJ; Coppola D; Sebti SM; Chen DT; Malafa MP
PLoS One; 2013; 8(2):e52526. PubMed ID: 23393547
[TBL] [Abstract][Full Text] [Related]
37. A novel target of mizoribine inhibiting mesangial cell proliferation: S phase kinase-associated protein 2.
Liu S; Xie Y; Lv Y; Qin F; Fu B; Shi S; Yin Z; Hong Q; Zhang X; Wang J; Chang M; Chen X
Am J Nephrol; 2010; 32(5):447-55. PubMed ID: 20924167
[TBL] [Abstract][Full Text] [Related]
38. Vorinostat enhances protein stability of p27 and p21 through negative regulation of Skp2 and Cks1 in human breast cancer cells.
Uehara N; Yoshizawa K; Tsubura A
Oncol Rep; 2012 Jul; 28(1):105-10. PubMed ID: 22484732
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of F-Box protein p45(SKP2) expression and stabilization of cyclin-dependent kinase inhibitor p27(KIP1) in vitamin D analog-treated cancer cells.
Lin R; Wang TT; Miller WH; White JH
Endocrinology; 2003 Mar; 144(3):749-53. PubMed ID: 12586749
[TBL] [Abstract][Full Text] [Related]
40. BCR signals target p27(Kip1) and cyclin D2 via the PI3-K signalling pathway to mediate cell cycle arrest and apoptosis of WEHI 231 B cells.
Banerji L; Glassford J; Lea NC; Thomas NS; Klaus GG; Lam EW
Oncogene; 2001 Nov; 20(50):7352-67. PubMed ID: 11704865
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
